Notice of Change to Foreign Component Eligibility in RFA-MH-18-706, "Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34- Clinical Trial Required)"

Notice Number: NOT-MH-19-058

Key Dates
Release Date: October 7, 2019

Related Announcements
RFA-MH-18-706

Issued by
National Institute of Mental Health (NIMH)

Purpose

The purpose of this Notice is to change the Foreign Component Eligibility in RFA-MH-18-706, "Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34- Clinical Trial Required)" to allow for Foreign components, as defined in the NIH Grants Policy StatementSection III.1 Eligible Applicants, Eligible Organizations, Foreign Institutions subsection has been updated to reflect this change:

Currently:
Foreign Institutions
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statementare not allowed.

Modified to read:
Foreign Institutions
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statementare allowed.

All other aspects of this Funding Opportunity Announcement remain the same.

Inquiries

Please direct all inquiries to:

Joel Sherrill, Ph.D.
National Institute of Mental Health (NIMH)
Telephone: 301-443-2477
Email: jsherril@mail.nih.gov